Heart disease is a reality that became personal for Zennia Thomas in the middle of her college basketball career.
At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results